Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pre-post Study Evaluating the Safety and Efficacy of Ibogaine-Magnesium Therapy in Veterans With Sequelae of Repeated Blast Exposure

NCT04313712 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT04313712
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04313712 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pre-post Study Evaluating the Safety and Efficacy of Ibogaine-Magnesium Therapy in Veterans With Sequelae of Repeated Blast Exposure
Lead sponsor
Stanford University
Phase
Observational
Overall status
Active, not recruiting
Start date
November 15, 2021
Completion date
February 28, 2025
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blast or combat exposure, head injury trauma